Newsroom

Presenting new therapeuthic solutions to a global audience

Our platform has too much potential to keep it secret. Which is why we publish, inform, and present. After all, you want to know where your future therapies are starting.

Press contact

eleva GmbH
Fabienne Zeitter
pr@elevabiologics.com
Phone: +49 761 470 99 0

News archive

Björn Cochlovius New CEO of Eleva

Markus Reichert2023-09-22T18:38:02+02:00Mai 3, 2023|

Eleva Enters Clinical Development of Difficult-To-Express High-Potential Proteins

Markus Reichert2023-09-22T18:46:41+02:00Oktober 12, 2021|

Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H

Markus Reichert2023-09-22T18:51:02+02:00September 14, 2021|

Navigo Proteins and Eleva Announce Successful Development of an Affinity Chromatography Resin Customized for the Efficient Purification of Human Complement-Factor H

Markus Reichert2023-09-22T18:54:49+02:00März 16, 2021|

Eleva secures up to EUR 60 million to advance a drug candidate, appoints new board member

Markus Reichert2023-09-22T18:58:08+02:00Januar 6, 2021|

Eleva’s drug candidate to be examined for use in Covid-19 treatment

Markus Reichert2023-09-22T19:03:16+02:00Juni 3, 2020|

Greenovation transforms into Eleva

Markus Reichert2023-09-22T19:06:03+02:00Mai 18, 2020|

Meet us here

Oct 05 2023 – Oct 08 2023

Jahrestagung der DGfN

Berlin, Germany

Oct 10 2023 – Oct 12 2023

Festival of Biologics

Nov 02 2023 – Nov 05 2023

ASN Kidney Week 2023

Philadelphia, USA

Nov 06 2023 – Nov 08 2023

BIO-Europe

Munich, Germany

Jan 08 2024 – Jan 11 2024

JPM Healthcare Conference 2024

San Francisco, CA, USA

Mar 18 2024 – Mar 20 2024

BIO Europe Spring

Barcelona, Spain